marketcap
Facebook
X
TelegramQuarterly report 2025-Q2
added 08-13-2025
Aethlon Medical Net Debt 2011-2025 | AEMD
Net Debt can be roughly defined as financial liabilities that an entity classifies in the financing section together with the resources available to service those financial liabilities[1]
Net debt is the obligations that remain after deducting all assets and other liabilities from a company or individual. It represents the sum of debts that an organization or person must repay to their creditors or other parties.
Net debt can include various types of obligations such as loans, borrowings, lease liabilities, or credit card payments. It is important to note that net debt does not include current expenses or obligations such as payroll expenses or current bills.
Assessing net debt is an important financial indicator for evaluating the financial position of a company or individual. If net debt significantly exceeds assets, it may indicate financial difficulties and insolvency. In such cases, the company or individual may face difficulties in meeting their obligations and managing their finances.
Net debt can also be used to compare the financial stability of different companies. The lower the net debt relative to assets, the more stable and financially sound they are considered.
Overall, understanding net debt helps evaluate the financial soundness and ability of a company to meet their obligations. It is an important indicator that assists in making decisions about lending, investments, and financial management.
Annual Net Debt Aethlon Medical
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| -4.85 M | -4.5 M | -13.3 M | -16.3 M | - | -9.46 M | -2.87 M | -6.13 M | -1.04 M | -1.6 M | -700 K | 1.28 M | 2.56 M | 3.52 M | 2.36 M |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 3.52 M | -16.3 M | -3.65 M |
References
- Pizzo, M., Moscariello, N., & Vinciguerra, R. (2015). Market Incentives and Regulators' Activity Shaping Financial Information: An Analysis of the Net Debt Disclosure in Italy. International Journal of Business and Management, 10(1), 1.
Net Debt of other stocks in the Medical devices industry
| Issuer | Net Debt | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
 |
Dynatronics Corporation
DYNT
|
1.8 M | $ 0.24 | 14.99 % | $ 929 K |  USA |
 |
Aziyo Biologics
AZYO
|
1.36 M | $ 1.48 | 1.37 % | $ 20.5 M | USA |
 |
Natus Medical Incorporated
NTUS
|
-64.1 M | $ 31.08 | 1.94 % | $ 1.05 B | USA |
 |
Obalon Therapeutics, Inc.
OBLN
|
6.46 M | $ 3.05 | -5.86 % | $ 30.6 M | USA |
 |
FONAR Corporation
FONR
|
-42.8 M | $ 15.1 | 2.72 % | $ 99 M | USA |
 |
Cardiovascular Systems
CSII
|
-64.6 M | $ 20.0 | 0.15 % | $ 844 M | USA |
 |
Neovasc
NVCN
|
-4.95 M | $ 30.03 | - | $ 111 M |  Canada |
 |
Apollo Endosurgery
APEN
|
-22.5 M | $ 10.0 | - | $ 475 M | USA |
 |
Integer Holdings Corporation
ITGR
|
941 M | $ 69.02 | 1.11 % | $ 2.32 B | USA |
 |
Titan Medical
TMDI
|
-31 M | $ 0.14 | -26.32 % | $ 19.6 M | Canada |
 |
OrthoPediatrics Corp.
KIDS
|
31.3 M | $ 16.81 | -1.18 % | $ 388 M | USA |
 |
Pulmonx Corporation
LUNG
|
-36.1 M | $ 1.95 | 1.56 % | $ 76.3 M | USA |
 |
Medtronic PLC
MDT
|
23.6 B | $ 92.46 | 0.28 % | $ 119 B | USA |
 |
Viveve Medical
VIVE
|
-6.52 M | $ 0.22 | -15.35 % | $ 1.71 M | USA |
 |
Invacare Corporation
IVC
|
299 M | $ 0.66 | - | $ 24.7 M | USA |
 |
Abiomed
ABMD
|
-227 M | $ 381.02 | - | $ 17.2 B | USA |
 |
Allied Healthcare Products
AHPI
|
-3.31 M | $ 0.55 | 3.58 % | $ 2.21 M | USA |
 |
Myomo
MYO
|
-4.79 M | $ 0.91 | 6.61 % | $ 6.42 M | USA |
 |
CryoLife, Inc.
CRY
|
230 M | $ 17.84 | -4.14 % | $ 702 M | USA |
 |
GenMark Diagnostics, Inc.
GNMK
|
38.7 M | $ 24.04 | - | $ 1.77 B | USA |
 |
Soliton, Inc.
SOLY
|
-31.6 M | $ 20.12 | -1.42 % | $ 435 M | USA |
 |
Hancock Jaffe Laboratories, Inc.
HJLI
|
-9.02 K | $ 10.38 | -1.98 % | $ 98.3 M | USA |
 |
Itamar Medical Ltd.
ITMR
|
-2.3 M | $ 30.65 | 0.03 % | $ 1.58 B |  Israel |
 |
Misonix, Inc.
MSON
|
5.72 M | $ 26.54 | - | $ 462 M | USA |
 |
Quanterix Corporation
QTRX
|
-133 M | $ 5.11 | 3.34 % | $ 192 M | USA |
 |
AVITA Medical
RCEL
|
29.1 M | $ 3.96 | 4.91 % | $ 102 M |  Australia |
 |
ShockWave Medical
SWAV
|
407 M | $ 334.75 | - | $ 12.3 B | USA |
 |
SeaSpine Holdings Corporation
SPNE
|
-75 M | $ 7.16 | 0.28 % | $ 270 M | USA |
 |
ViewRay
VRAY
|
-59.8 M | $ 2.64 | 1.54 % | $ 468 M | USA |
 |
Intersect ENT, Inc.
XENT
|
50.8 M | $ 28.24 | - | $ 955 M | USA |
 |
STRATA Skin Sciences
SSKN
|
2.4 M | $ 1.68 | 2.44 % | $ 58.3 M | USA |
 |
Axonics Modulation Technologies
AXNX
|
-230 M | $ 70.98 | - | $ 3.31 B | USA |
 |
BIOLASE
BIOL
|
6.1 M | $ 0.13 | -13.19 % | $ 166 K | USA |
 |
Eargo
EAR
|
-97.8 M | $ 2.57 | - | $ 10.2 M | USA |
 |
Delcath Systems
DCTH
|
-2.46 M | $ 8.61 | -0.35 % | $ 245 M | USA |
 |
SmileDirectClub
SDC
|
763 M | $ 0.08 | -53.45 % | $ 9.71 M | USA |
 |
ThermoGenesis Holdings
THMO
|
-4.05 M | $ 0.31 | -25.84 % | $ 171 K | USA |
 |
Acutus Medical
AFIB
|
14.2 M | $ 0.09 | -26.83 % | $ 2.62 M | USA |
 |
ClearPoint Neuro
CLPT
|
-16.5 M | $ 16.44 | 3.98 % | $ 444 M | USA |
 |
Surgalign Holdings
SRGA
|
-5.5 M | $ 0.18 | -32.98 % | $ 1.68 M | USA |
 |
Conformis
CFMS
|
-26.2 M | $ 2.27 | - | $ 16.4 M | USA |
 |
Sientra
SIEN
|
12.3 M | $ 0.18 | -16.59 % | $ 10.3 M | USA |
 |
NuVasive
NUVA
|
-238 M | $ 39.75 | - | $ 2.07 B | USA |
 |
Cutera
CUTR
|
-140 M | $ 0.1 | -10.19 % | $ 1.99 M | USA |
 |
Nemaura Medical
NMRD
|
-23.5 K | $ 0.11 | -17.8 % | $ 2.74 M |  Britain |
 |
Vapotherm
VAPO
|
-4.39 M | $ 1.27 | 6.72 % | $ 34 M | USA |
 |
Globus Medical
GMED
|
-774 M | $ 86.3 | 2.87 % | $ 11.7 B | USA |
 |
Viemed Healthcare
VMD
|
-22.6 M | $ 6.39 | 0.31 % | $ 245 M | USA |